1919 Investment Counsel’s Pfizer PFE Stock Holding History

1919 Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$13.4M	Buy	477,219 +31,200	+7%	+$876K	0.28%	93
2014 Q2	$12.6M	Buy	446,019 +55,545	+14%	+$1.58M	0.26%	95
2014 Q1	$11.9M	Sell	390,474 -6,110	-2%	-$182K	0.24%	93
2013 Q4	$11.5M	Buy	396,584 +2,350	+0.6%	+$68.4K	0.24%	92
2013 Q3	$10.7M	Buy	394,234 +727	+0.2%	+$19.8K	0.24%	95
2013 Q2	$10.5M	Buy	+393,507	New	+$10.9M	0.24%	94

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1919 Investment Counsel's PFE Position: Q3 2014 in Review

1919 Investment Counsel increased its Pfizer (PFE) stake by 7% in Q3 2014, buying an estimated $876K and bringing the position to 477,219 shares worth $13.4M. The position accounts for 0.28% of the portfolio, ranked #93.

1919 Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

1919 Investment Counsel held 477,219 shares of Pfizer worth $13.4M as of Q3 2014.
1919 Investment Counsel bought 31,200 Pfizer shares in Q3 2014, an estimated $876K.
Pfizer made up 0.28% of 1919 Investment Counsel's portfolio in Q3 2014, its #93 holding.
1919 Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.